GOSH tribute to Professor Maria Bitner-Glindzicz

21 Sep 2018, 9:27 a.m.

GOSH issued the following statement:"It is with profound sadness that we learnt of the death of Professor Maria Bitner-Glindzicz, Clinical and Molecular Geneticist at Great Ormond Street Hospital and UCL Great Ormond Street Institute of Child Health.

“Maria was a true leader in her field, a very valued colleague, and internationally recognised for her contributions to genetics. Her important work focused on children and adults with sight and hearing loss. It included pioneering research into the genetic causes of deafness in children and therapies that she hoped would one day restore vision. She was a genuine advocate for her patients and an articulate voice who tirelessly pushed for greater support for children affected by sight and hearing impairments.

“Our deepest sympathies go out to Maria's family and friends at this very difficult time.”

NIHR launches £13.7m investment into brain tumour research

The National Institute for Health and Care Research (NIHR) has announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.

New consortium aims to help improve care for arthritis patients

A new UK-led research group, including Great Ormond Street Hospital and University College London, aims to improve the lives of children, young people and adults with arthritis by defining for the first time what being in ‘remission’ from arthritis truly

Great Ormond Street Hospital joins the Circular Economy Healthcare Alliance (CEHA)

By joining CEHA, Great Ormond Street Hospital reaffirms its commitment to ‘do no harm’—not only to our patients, but to the environment and future generations.

‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-Cell leukaemia

A groundbreaking new treatment using gene-edited immune cells, developed at GOSH and UCL has shown promising results in helping children and adults fight a rare and aggressive cancer